Search results for: 'next capture therapy'

Direct air carbon capture (DACC) is a negative-emission carbon dioxide reduction technology that directly captures CO2 from the air with solid or liquid adsorbents/solvents and then uses a heat source to desorb the CO2. It is a rapidly emerging and dynamic segment of the carbon capture, utilization, and storage industry. DACC is still in the e...

This study presents a comprehensive analysis of advanced carbon capture technologies as key enablers of industrial decarbonization in achieving global net-zero goals. It explores the integration of pre-combustion, post-combustion, and oxy-fuel pathways—each employing distinct sub-methods such as chemical looping, gas–liquid absorption, adsorption, ...

Carbon capture, utilization, and storage (CCUS) will have a huge role to play in the global decarbonization trend of industries. As energy transition speeds up and impending deadlines for the carbon neutrality approach, the CCUS market will present dynamic growth opportunities across regions and industrial sectors until 2030. In addition to th...

The growing need to achieve deep decarbonization in hard-to-abate industries and to address climate change is driving the large-scale deployment of carbon dioxide utilization technologies. Efficient carbon utilization technologies are required to scale up emission reduction to gigatons per annum in the coming years to meet Net-Zero Targets while re...

Carbon Capture, Utilization, and Storage (CCUS) will have a huge role to play in the global trend towards decarbonization of industries in the decades ahead. As energy transition accelerates and impending deadlines for carbon-neutrality approach, the CCUS market will present dynamic growth opportunities across regions and industrial sectors till 20...

16 Aug 2022  |  North America  |  Market Research

Global Cell and Gene Therapy (CGT) Growth Opportunities

The Shift to Prevalent Diseases and Allogeneic Cell Therapies Creates New Growth Opportunities in the CGT Value Chain

Infographics

×

This Frost & Sullivan study examines the global cell and gene therapy (CGT) market. It highlights revenue forecasts and key growth opportunities for CGT market participants based on the evolution of their business models and strategic approaches as well as investments and regulations. The study segments the market by product (cell therapy, gene-mod...

Carbon Capture, Utilization, and Storage (CCUS) will play a huge role in the global shift toward decarbonization of industries in the decades ahead. As the global energy transition accelerates and impending deadlines for a carbon-neutrality approach, the CCUS market will present dynamic growth opportunities across regions and industrial sectors to ...

The Frost & Sullivan research service discusses the cell and gene therapy (CGT) market and highlights some key roadblocks in viral vector manufacturing. While many CGT candidates exist in the pipeline, there is a huge capacity deficit that the industry is collaboratively trying to address. Scalability, costs, reproducibility, and overall process ef...

Rare diseases pose a global burden to healthcare despite making up a very small fraction of the global disease landscape. Most treatment options for rare diseases focus on maintaining the disease symptoms, rather than a disease-modifying approach. To address this unmet need, RNA therapies are emerging as disease-modifying approaches addressing the ...